Neurocrine Biosciences: Q2 Earnings Insights

Neurocrine Biosciences NBIX reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Neurocrine Biosciences beat estimated earnings by 42.37%, reporting an EPS of $0.84 versus an estimate of $0.59.

Revenue was up $89.30 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 3.53% drop in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.34 0.52 0.60 0.49
EPS Actual 0.30 0.04 0.64 0.63
Revenue Estimate 303.40M 316.79M 297.65M 274.38M
Revenue Actual 310.60M 312.00M 296.00M 288.90M

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

NBIX Logo
NBIXNeurocrine Biosciences Inc
$107.411.56%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
28.82
Growth
82.32
Quality
39.05
Value
55.51
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...